Abstract

The vascular factor in Alzheimer’s disease (AD), affecting its development and progression, is one of the most urgent problems of modern neuroangiology. The research investigates the characteristics of cerebral angioarchitectonics identified at different stages of AD. The research included 106 patients: 1) The Test Group—47 patients suffering from various stages of AD; 2) The Control Group—59 patients suffering from the most common lesions of the brain accompanied by neurodegenerative changes, the development of dementia and cognitive impairment, but not having AD. All the patients underwent: the testing of cognitive functions (MMSE), the determination of severity of dementia (CDR) and AD stages (TDR), computed tomography (CT), magnetic resonance imaging (MRI), scintigraphy of the brain (SG), rheoencephalography (REG), and cerebral multigated angiography (MUGA). Patients with AD different stages showed the following changes in angioarchitectonics and microcirculation: Absence of pronounced atherosclerotic lesions of intracranial vessels, reduction of the capillary bed in the temporal and temporo-parietal regions, development of multiple arteriovenous shunts in the same areas, early venous discharge, abnormal expansion of venous trunks that receive blood from arteriovenous shunts, venous congestion at the border of the frontal and parietal region, increased looping of intracranial arteries. Control Group patients had no combination of the abovementioned changes. These vascular changes are specific for AD and are in fact the vascular factor of this disease; they may also be called dyscirculatory angiopathy of Alzheimer’s type (DAAT). Patients suffering from other diseases that are accompanied by neurodegenerative changes in the brain, dementia and cognitive impairment do not have them.

Highlights

  • According to the Alzheimer’s Association, Alzheimer’s disease (AD) is becoming a global problem of modern mankind

  • No combination of such vascular disorders has been identified among any of Control Group patients indicating that it is specific for AD

  • Blood supply and microcirculation disorders in the temporal and fronto-parietal brain regions identified among Test Group patients, we can conclude that these disorders are specific for AD and are not specific for other diseases associated with the development of neurodegenerative changes in the brain burdened by the development of dementia and cognitive disorders

Read more

Summary

Introduction

According to the Alzheimer’s Association, Alzheimer’s disease (AD) is becoming a global problem of modern mankind. The number of patients suffering from this disease is increasing every year worldwide. In the United States there were 5.4 million patients in 2011 [1] and it is estimated that by 2050 the number of cases will increase to 13.5 million people [2], and in case of diagnosis and detection of preclinical stages of the disease this figure can considerably rise. In 2010, there were 35.6 million of identified cases worldwide, and by 2050 this figure is expected to increase to 115.4 million while every other inhabitant of the planet at the age of 85 and older will get sick [1,3]. The introduction of CT and MRI contributed to successfully study the lifetime neurodegenerative changes that occur in the brain tissue during the development of the disease [5,6,7]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call